
Research / Customization / Sales
Tesamorelin
Tesamorelin is a modified GHRH analogue investigated in endocrine and metabolic research.
- Specification
- 5mg × 10 vials
- Catalog code
- TSM5
- Material category
- Peptide
Choose a contact to discuss this specification, quantity or customization.
For laboratory research use only. Not for human use.
The research context
A closer look at Tesamorelin.
GHRH-receptor signaling and endocrine research
Certificate of Analysis
Tesamorelin
- Sample
- Tesamorelin 20mg
- Spec.
- 20mg
- Laboratory
- pH Solutions Lab
- Report ID
- 260923-899-NHS-9
- Issued date
- Oct 7, 2026
Technical Details Product information
Tesamorelin parent
- CAS
- 218949-48-5
- formula
- C221H366N72O67S
- mass
- 5135.86
- sequence
- trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
Storage: Lyophilized material: -20°C, light/moisture-protected; solution: 2–8°C.
Tesamorelin acetate, variable acetate content
- CAS
- 901758-09-6
- formula
- C221H366N72O67S.xC2H4O2
- mass
- 5135.78 + x(60.05)
FAQ
Tesamorelin questions
What is Tesamorelin?
Tesamorelin is a modified GHRH analogue investigated in endocrine and metabolic research.
Which specifications and packs are listed?
5mg × 10 vials; 10mg × 10 vials; 20mg × 10 vials.
Can I request a different specification?
Yes. Contact our team on WhatsApp or Telegram to discuss specifications and customization.
Where can I view its COA?
Select View COA on this product page or browse Quality & COA.
Let's discuss your specification
Make Tesamorelin part of your project.
Your enquiry includes the selected specification and catalog code.



